TABLE 3.
Summary of Efficacy Results: Sensitivity
| Moderate Dysplasia or Worse | Moderate/Severe Dysplasia/CIS | |||||
|---|---|---|---|---|---|---|
| Unit of Analysis |
WLB | WLB + ARB | Relative Sensitivity (95% CI) |
WLB | WLB + ARB | Relative Sensitivity (95% CI) |
| Lesion | 47% | 71% | 1.50 (1.26–1.89) | 10% | 44% | 4.25 (2.00–16.0) |
| Patient | 56% | 74% | 1.33 (1.13–1.70) | 16% | 56% | 3.50 (1.63–12.0) |
CIS, carcinoma in situ; WLB, white light bronchoscopy; ARB, autofluorescence-reflectance bronchoscopy; CI, confidence interval.